Dietary casein phosphopeptides prevent bone loss in aged ovariectomized rats

Area of Science:

• Biochemistry
• Nutrition Science
• Bone Biology

Background:

• Osteoporosis is a significant health concern, particularly in post-menopausal women, leading to bone loss.
• Ovariectomized (OVX) rats serve as a standard animal model to study post-menopausal bone loss.
• Dietary interventions are crucial for managing bone health and preventing osteoporosis.

Purpose of the Study:

• To investigate the effects of dietary calcium-bound casein phosphopeptides (CaCPP) on bone mineral density in aged OVX rats.
• To evaluate CaCPP as a potential therapeutic agent for preventing bone loss associated with estrogen deficiency.
• To understand the impact of CaCPP on calcium and phosphorus metabolism in the context of bone health.

Main Methods:

• Three groups of OVX rats and one sham-operated (SHAM) group were fed experimental or control diets for 17 weeks.
• Experimental diets included CaCPP as the sole calcium source or Ca-free casein phosphopeptides (CPP).
• Bone mineral density (BMD) was measured in vivo and ex vivo; serum markers and urinary excretion of calcium and phosphorus were analyzed.

Main Results:

• OVX rats fed CaCPP showed maintained femoral BMD, while control OVX rats experienced decreased BMD.
• Ex vivo analysis revealed significantly higher BMD in femurs from rats fed CaCPP compared to controls.
• No significant differences in serum markers of bone metabolism were observed among OVX groups, but urinary calcium and phosphorus excretion patterns differed.

Conclusions:

• Dietary CaCPP demonstrates a protective effect against bone loss in aged OVX rats, suggesting its potential in osteoporosis management.
• The bone-protective effects of CaCPP may be mediated through alterations in calcium and phosphorus metabolism.
• CaCPP represents a promising dietary strategy for maintaining bone health in conditions mimicking post-menopausal bone loss.